| Sweetie Sangeeta Krishen, MD | |
|
304 Wright St, Sweetwater, TN 37874-1181 | |
| (865) 213-8401 | |
| (865) 213-8596 |
| Full Name | Sweetie Sangeeta Krishen |
|---|---|
| Gender | Female |
| Speciality | Pediatrics |
| Location | 304 Wright St, Sweetwater, Tennessee |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1568417111 | NPI | - | NPPES |
| 1693197 | Medicaid | LA | |
| Q028139 | Medicaid | TN | |
| 8901854 | Other | TN | BLUE CROSS BLUE SHIELD |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208000000X | Pediatrics | MD55274 (Tennessee) | Secondary |
| 208000000X | Pediatrics | MD.022295 (Louisiana) | Primary |
| Entity Name | Sweetwater Hospital Association |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1558995399 PECOS PAC ID: 6608773775 Enrollment ID: O20210226000607 |
News Archive
ACC and its member companies have long-supported research to advance scientific understanding about chemicals and promote public health. To achieve these goals, that research should be based on sound scientific principles so as to be meaningful to human health. There are significant limitations in the study design, highlighted by the authors themselves, which limit the utility of the study.
Cosmetic considerations and a perceived lack of patent opportunities could be stopping the pharmaceutical and healthcare industries from investing in the development of a new therapy proven to be effective in the treatment of MRSA.
In the fight against emerging infectious diseases, The Galveston National Laboratory (GNL), one of two National Institutes of Health funded bio-containment laboratories in the United States, is benefiting from IBM software to ensure the optimal performance of all equipment functioning within its facility. The GNL, which is dedicated to the study and prevention of emerging infectious diseases, will use IBM Maximo Asset Management Software to help automate, manage and ensure the performance of its 3,000 operating assets in one of the world's most complex medical research environments.
Researchers at Georgetown University Medical Center have used tiny doses of a leukemia drug to halt accumulation of toxic proteins linked to Parkinson's disease in the brains of mice. This finding provides the basis to plan a clinical trial in humans to study the effects.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Sweetie Sangeeta Krishen, MD 304 Wright St, Sweetwater, TN 37874-1181 Ph: (865) 213-8401 | Sweetie Sangeeta Krishen, MD 304 Wright St, Sweetwater, TN 37874-1181 Ph: (865) 213-8401 |
News Archive
ACC and its member companies have long-supported research to advance scientific understanding about chemicals and promote public health. To achieve these goals, that research should be based on sound scientific principles so as to be meaningful to human health. There are significant limitations in the study design, highlighted by the authors themselves, which limit the utility of the study.
Cosmetic considerations and a perceived lack of patent opportunities could be stopping the pharmaceutical and healthcare industries from investing in the development of a new therapy proven to be effective in the treatment of MRSA.
In the fight against emerging infectious diseases, The Galveston National Laboratory (GNL), one of two National Institutes of Health funded bio-containment laboratories in the United States, is benefiting from IBM software to ensure the optimal performance of all equipment functioning within its facility. The GNL, which is dedicated to the study and prevention of emerging infectious diseases, will use IBM Maximo Asset Management Software to help automate, manage and ensure the performance of its 3,000 operating assets in one of the world's most complex medical research environments.
Researchers at Georgetown University Medical Center have used tiny doses of a leukemia drug to halt accumulation of toxic proteins linked to Parkinson's disease in the brains of mice. This finding provides the basis to plan a clinical trial in humans to study the effects.
› Verified 7 days ago
Syed Mohammad Amer, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 304 Church St, Sweetwater, TN 37874 Phone: 865-213-8593 Fax: 865-213-8596 | |
Wendy Nannette Saint Robbins, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 304 Church St, Sweetwater, TN 37874 Phone: 865-213-8593 Fax: 865-213-8596 |